MedTrace Logo

Naltrexone Augmentation of Nicotine Patch Therapy - 1

NCT00218153 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-01-12

No results posted yet for this study

Summary

Naltrexone Augmentation of Nicotine Patch Therapy

Conditions

  • Tobacco Use Disorder

Interventions

DRUG

Naltrexone

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Stephanie O'Malley, Ph.D. · Substance Abuse Treatment Unit

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-11-30
Completion
2004-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00218153 on ClinicalTrials.gov